From July 1, 2023 to September 30, 2023, the company has repurchased 40,000 shares, representing 2.8% for $0.19 million. With this, the company has completed the repurchase of 40,000 shares, representing 2.8% for $0.19 million under the buyback announced on June 12, 2023.
Creative Medical Technology Holdings, Inc.
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.43 USD | -3.70% | -0.23% | -3.90% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.90% | 6.24M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- CELZ Stock
- News Creative Medical Technology Holdings, Inc.
- Tranche Update on Creative Medical Technology Holdings, Inc.'s Equity Buyback Plan announced on June 12, 2023.